Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,378 | 1,930 | 2,419 | 2,543 | 1,881 | 1,806 | 2,580 | 2,385 | 2,160 | 1,785 | | 1,785 |
% Growth | NA | 40.1% | 25.3% | 5.2% | -26.0% | -4.0% | 42.8% | -7.6% | -9.4% | -17.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,232) | (1,436) | (1,874) | (2,153) | (1,710) | (1,641) | (2,235) | (2,396) | (2,078) | (1,737) | | (1,737) |
Gross Profit | 146 | 494 | 545 | 390 | 171 | 165 | 345 | (11) | 82 | 48 | | 48 |
% Revenue | 10.6% | 25.6% | 22.5% | 15.4% | 9.1% | 9.1% | 13.4% | -0.5% | 3.8% | 2.7% | | 2.7% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (42) | (43) | (42) | (39) | (42) | (50) | (53) | (62) | (69) | (45) | | (45) |
General and Admin | (25) | (28) | (38) | (37) | (43) | (34) | (39) | (43) | (41) | (60) | | (60) |
Other Inc / (Exp) | (8) | 3 | (11) | (19) | (7) | (2) | 4 | 10 | 14 | 10 | | 10 |
Total Operating Exp | (74) | (67) | (92) | (94) | (91) | (86) | (87) | (95) | (96) | (95) | | (95) |
| | | | | | | | | | | | |
Operating Income | 71 | 427 | 453 | 296 | 80 | 79 | 258 | (106) | (14) | (47) | | (47) |
% Revenue | 5.2% | 22.1% | 18.7% | 11.6% | 4.3% | 4.4% | 10.0% | -4.4% | -0.6% | -2.6% | | -2.6% |
| | | | | | | | | | | | |
Interest Expense | (15) | (27) | (29) | (42) | (48) | (56) | (56) | (71) | (40) | (41) | | (41) |
Pre-tax Income | 56 | 401 | 425 | 254 | 33 | 23 | 202 | (176) | (54) | (88) | | (88) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (30) | (100) | (105) | (72) | (9) | 29 | (50) | 27 | 23 | 31 | | 31 |
Net Income to Company | 26 | 300 | 319 | 182 | 24 | 52 | 152 | (149) | (32) | (57) | | (57) |
% Margin | 1.9% | 15.5% | 13.2% | 7.2% | 1.3% | 2.9% | 5.9% | -6.3% | -1.5% | -3.2% | | -3.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | (0) | (1) | (1) | (1) | (0) | 0 | (0) | (2) | (12) | | (12) |
Net Income to Stockholders | 26 | 300 | 319 | 182 | 23 | 51 | 152 | (150) | (34) | (69) | | (69) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 26 | 300 | 319 | 182 | 23 | 51 | 152 | (150) | (34) | (69) | | (69) |
% Margin | 1.9% | 15.5% | 13.2% | 7.1% | 1.2% | 2.8% | 5.9% | -6.3% | -1.6% | -3.9% | | -3.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.00) | (0.00) | (0.00) | | (0.00) |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.00) | (0.00) | (0.00) | | (0.00) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 65,739.25 | 66,842.95 | 68,381.01 | 71,334.08 | 71,334.08 | 77,639.12 | 71,030.24 | 71,030.24 | 71,030.24 | 71,030.24 | | 71,030.24 |
WA Diluted Shares Out. | 65,739.25 | 66,842.95 | 68,381.01 | 71,334.08 | 71,334.08 | 77,639.12 | 71,030.24 | 71,030.24 | 71,030.24 | 71,030.24 | | 71,030.24 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 56 | 401 | 425 | 254 | 33 | 23 | 202 | (176) | (54) | (88) | | (88) |
Addback: Net Interest Expense | 15 | 27 | 29 | 42 | 48 | 56 | 56 | 71 | 40 | 41 | | 41 |
Addback: Other Non Operating Expenses, Total | 8 | (3) | 11 | 19 | 7 | 5 | (4) | (10) | (14) | (10) | | (10) |
Addback: Depreciation & Amortization | 64 | 75 | 79 | 82 | 88 | 102 | 97 | 96 | 110 | 112 | | 112 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | (2) | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 143 | 499 | 544 | 397 | 174 | 183 | 351 | (21) | 82 | 55 | | 55 |
% Margin | 10.4% | 25.8% | 22.5% | 15.6% | 9.3% | 10.1% | 13.6% | -0.9% | 3.8% | 3.1% | | 3.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 79 | 424 | 464 | 315 | 87 | 81 | 254 | (116) | (28) | (57) | | (57) |
% Margin | 5.8% | 22.0% | 19.2% | 12.4% | 4.6% | 4.5% | 9.8% | -4.9% | -1.3% | -3.2% | | -3.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 26 | 300 | 319 | 182 | 24 | 52 | 152 | (149) | (32) | (57) | | (57) |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | (2) | 0 | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | 0 |
Adjusted Net Income | 26 | 300 | 319 | 182 | 24 | 50 | 152 | (149) | (32) | (57) | | (57) |
% Margin | 1.9% | 15.5% | 13.2% | 7.2% | 1.3% | 2.8% | 5.9% | -6.3% | -1.5% | -3.2% | | -3.2% |